Tourette’s syndrome results from a combination of genetic susceptibility and environmental factors that together disrupt how the brain controls movement. No single gene or event causes it. Instead, multiple influences converge on a specific set of brain circuits, leading to the repetitive, involuntary movements and vocalizations known as tics. The condition affects roughly 1 in 162 children, with symptoms typically appearing between ages 5 and 10, and boys are diagnosed about four times more often than girls.
Genetics Play a Major but Incomplete Role
Tourette’s runs in families, but it doesn’t follow a simple inheritance pattern like eye color. Twin studies consistently show that identical twins are far more likely to share the condition than fraternal twins, confirming a strong genetic component. Heritability estimates from large population studies generally fall between 28% and 56%, depending on how tics are defined and measured. One study of over 20,000 adult twins estimated tic heritability at 33%, while studies focused on clinical Tourette’s diagnoses have placed it closer to 50% or above.
These numbers mean genetics account for a substantial chunk of who develops Tourette’s, but they also leave room for non-genetic factors. Researchers have not identified a single “Tourette’s gene.” Instead, the condition likely involves many common genetic variants, each contributing a small amount of risk. When a parent has Tourette’s, their child has a higher chance of developing tics, but it’s far from guaranteed, and the severity can vary enormously within the same family.
A Brain Circuit That Loses Its Brakes
The brain structures most consistently linked to Tourette’s form a loop that connects the outer layer of the brain (the cortex) to a cluster of deep structures called the basal ganglia, then to the thalamus, and back to the cortex. This loop, sometimes called the CSTC circuit, is responsible for selecting which movements to execute and, critically, which ones to suppress.
In a typical brain, the cortex sends movement plans down to the striatum, the entry point of the basal ganglia. From there, signals travel through two competing pathways: a “go” pathway that allows a movement to proceed, and a “stop” pathway that blocks it. These pathways converge on the thalamus, which relays the final decision back to the motor cortex. In Tourette’s, the balance tips toward the “go” side. The striatum appears to generate abnormal excitatory signals that release motor programs the brain would normally keep in check. The result is a tic: a movement or sound that the person didn’t choose to make.
This same circuit also handles cognitive and emotional information through parallel loops, which helps explain why Tourette’s so often comes with attention problems, compulsive behaviors, and difficulty with impulse control.
Dopamine and Other Chemical Imbalances
The strongest chemical evidence points to dopamine, the neurotransmitter most involved in movement, motivation, and reward. The brains of people with Tourette’s appear to have lower baseline levels of dopamine floating between nerve cells, but when dopamine is released in bursts (during stimulation or excitement), the response is exaggerated. This combination of low resting dopamine and hyperreactive dopamine spikes may be why tics worsen during stress or excitement and improve during calm, focused activity.
Supporting this theory, medications that block dopamine receptors are among the most effective treatments for reducing tics. Postmortem brain studies have also found that dopamine receptors in the basal ganglia are more numerous or more sensitive than normal, as if the brain is compensating for the low baseline levels by turning up the volume on its receivers.
Glutamate, the brain’s main excitatory chemical messenger, also appears to be involved. Reduced glutamate levels have been found in postmortem Tourette’s brains, though exactly how this connects to tic generation is less well understood than the dopamine link.
Prenatal and Early Life Risk Factors
Even with a genetic predisposition, environmental exposures during pregnancy and birth can push the odds higher. A systematic review of prenatal risk factors found that maternal smoking during pregnancy and low birth weight were the most consistently reported associations with Tourette’s onset. The proposed mechanism ties back to the dopamine system: early brain injury or toxic exposure during critical periods of fetal development may alter how dopamine pathways form, priming the CSTC circuit for dysfunction later in childhood.
Other prenatal and birth complications that have been linked to increased risk include severe nausea and vomiting during pregnancy, complications during delivery, and prematurity. None of these factors cause Tourette’s on their own. They appear to act as additional stressors on a brain that is already genetically vulnerable.
Infections and the Immune System
In a small subset of children, tics appear suddenly after a bacterial or viral infection. The best-studied version of this is PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections), in which symptoms erupt roughly four to six weeks after a strep throat or similar infection. The child may go from having no tics to developing noticeable motor or vocal tics, obsessive-compulsive behaviors, anxiety, mood swings, and sometimes developmental regression, all within days.
The mechanism involves molecular mimicry. Strep bacteria disguise themselves by mimicking the surface of human cells. When the immune system mounts an attack, the antibodies it produces can cross the blood-brain barrier and mistakenly bind to cells in the basal ganglia. This triggers inflammation in the very circuit responsible for movement control. A broader category called PANS includes similar sudden-onset neuropsychiatric symptoms triggered by other infections, including Lyme disease, mycoplasma pneumonia, herpes simplex, and varicella (chickenpox).
PANDAS and PANS are considered diagnoses of exclusion, meaning doctors look for them after ruling out other explanations. Key diagnostic features include onset between ages 3 and 12, a dramatic and sudden appearance of symptoms, and a confirmed temporal link to an infection. Children with a family history of autoimmune disease or rheumatic fever face higher risk.
Why ADHD and OCD So Often Appear Alongside Tics
Tourette’s rarely travels alone. A majority of people diagnosed with the condition also meet criteria for ADHD, OCD, or both. This isn’t coincidence. Brain imaging studies of all three conditions consistently implicate the same CSTC circuits, and family studies suggest the overlap is at least partially genetic. In families where Tourette’s is present, relatives have elevated rates of both ADHD and OCD even when they don’t have tics themselves.
One analysis of over 200 Tourette’s families identified a specific subgroup where all three conditions, Tourette’s, OCD, and ADHD, cluster together. This combined subtype was the most heritable of all the patterns studied, suggesting it may represent a distinct and more severe form of the underlying neurobiology rather than three separate conditions happening to co-occur. The shared involvement of the basal ganglia makes sense: different loops within the same circuit handle motor control (tics), behavioral inhibition (ADHD), and habit formation (OCD). A disruption broad enough to affect the striatum could easily spill across all three.
Why Boys Are Diagnosed More Often
The roughly 4-to-1 male-to-female ratio in Tourette’s diagnoses is one of the most consistent findings in the field. Twin studies show slightly higher heritability in boys (around 39%) compared to girls (around 26%), suggesting that biological sex influences how strongly genetic risk translates into actual symptoms. The reasons for this gap remain unclear, but hormonal differences during brain development are a leading hypothesis. Testosterone and estrogen influence dopamine signaling in the basal ganglia, and the sex difference in Tourette’s prevalence tracks closely with the timing of puberty, which is also when many children see their tics peak and then begin to improve.
Prevalence drops sharply in adulthood. While roughly 1% of children and adolescents have Tourette’s, estimates for adults fall to around 0.01%. For most people, tics become significantly milder or disappear entirely by early adulthood, though a minority continue to experience symptoms throughout their lives.